1. Home
  2. BWAY vs TLS Comparison

BWAY vs TLS Comparison

Compare BWAY & TLS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • BWAY
  • TLS
  • Stock Information
  • Founded
  • BWAY 2003
  • TLS 1969
  • Country
  • BWAY Israel
  • TLS United States
  • Employees
  • BWAY N/A
  • TLS N/A
  • Industry
  • BWAY Medical/Dental Instruments
  • TLS EDP Services
  • Sector
  • BWAY Health Care
  • TLS Technology
  • Exchange
  • BWAY Nasdaq
  • TLS Nasdaq
  • Market Cap
  • BWAY 207.4M
  • TLS 188.7M
  • IPO Year
  • BWAY 2019
  • TLS 2020
  • Fundamental
  • Price
  • BWAY $8.76
  • TLS $1.96
  • Analyst Decision
  • BWAY Strong Buy
  • TLS Buy
  • Analyst Count
  • BWAY 3
  • TLS 6
  • Target Price
  • BWAY $13.17
  • TLS $4.13
  • AVG Volume (30 Days)
  • BWAY 24.0K
  • TLS 1.2M
  • Earning Date
  • BWAY 05-13-2025
  • TLS 05-09-2025
  • Dividend Yield
  • BWAY N/A
  • TLS N/A
  • EPS Growth
  • BWAY N/A
  • TLS N/A
  • EPS
  • BWAY 0.06
  • TLS N/A
  • Revenue
  • BWAY $41,016,000.00
  • TLS $109,269,000.00
  • Revenue This Year
  • BWAY $351.53
  • TLS $33.75
  • Revenue Next Year
  • BWAY $21.84
  • TLS $27.97
  • P/E Ratio
  • BWAY $57.37
  • TLS N/A
  • Revenue Growth
  • BWAY 29.04
  • TLS N/A
  • 52 Week Low
  • BWAY $5.13
  • TLS $1.89
  • 52 Week High
  • BWAY $11.79
  • TLS $5.03
  • Technical
  • Relative Strength Index (RSI)
  • BWAY 47.80
  • TLS 24.50
  • Support Level
  • BWAY $8.61
  • TLS $2.67
  • Resistance Level
  • BWAY $9.09
  • TLS $2.85
  • Average True Range (ATR)
  • BWAY 0.38
  • TLS 0.18
  • MACD
  • BWAY 0.05
  • TLS -0.05
  • Stochastic Oscillator
  • BWAY 58.73
  • TLS 12.04

About BWAY BrainsWay Ltd.

BrainsWay Ltd is engaged in advanced noninvasive neurostimulation treatments for mental health disorders. The company is advancing neuroscience with its proprietary Deep Transcranial Magnetic Stimulation (Deep TMS) platform technology to improve health and transform lives. Current indications include depressive disorder (including reduction of anxiety symptoms, commonly referred to as anxious depression), obsessive-compulsive disorder and smoking addiction. Additional clinical trials of Deep TMS in various psychiatric, neurological, and addiction disorders are underway. The company derives revenues from the lease and sale of Deep TMS systems.

About TLS Telos Corporation

Telos Corp offers technologically forwarded, software-based security solutions that empower and protect the world's security-conscious organizations against rapidly evolving, sophisticated, and pervasive threats. Its business has two reportable and operating segments namely Security Solutions and Secure Networks. The Security Solutions segment focuses on cybersecurity, cloud, and identity solutions, and the Secure Networks focuses on enterprise security. The company derives maximum revenue from the Security Solutions segment.

Share on Social Networks: